NCT01287520 - A Study of LY2090314 in Patients With Advanced or Metastatic Cancer | Biotech Hunter

Enrollment

41

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Advanced Cancer

Interventions

DRUG

LY2090314

Administered intravenously

DRUG

pemetrexed

Administered intravenously

DRUG

Carboplatin

Administered intravenously

OTHER

ranitidine

Per I2H-MC-JWYA Protocol Amendment (d) approved 11 March 2010, 50 mg ranitidine given as pretreatment to LY2090314 for stomach pain.

Trial Locations (2)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tampa

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nashville